Vesper Healthcare Acquisition (VSPRU) Stock Price, News & Analysis

Company Overview

Vesper Healthcare Acquisition Corp is a special purpose acquisition company incorporated in Delaware in 2020. The company’s units trade on the OTC Markets under the ticker VSPRU. Formed as a blank‐check vehicle, it was created to raise capital through an initial public offering and to acquire one or more businesses in the healthcare sector.

Vesper Healthcare Acquisition focuses on identifying targets across the healthcare continuum, including pharmaceutical development, medical devices, healthcare services and technology‐enabled care solutions. The company seeks to leverage its financial resources and structuring expertise to partner with management teams that have established track records and growth prospects. Its stated strategy is to pursue acquisitions primarily in North America, where it believes there are significant opportunities for scale and innovation in life sciences and health‐care delivery.

The sponsor and management team bring experience from investment banking, private equity and the healthcare industry, although no specific combination has been announced to date. As a blank‐check issuer, Vesper Healthcare Acquisition holds the proceeds of its IPO in a trust pending the completion of a qualifying business combination. Upon completion of a transaction, the company aims to transition from a holding entity into an operating public company with a dedicated focus on driving value in the healthcare sector.

Key Stats

• Today's Range: $13.83 to $14.81
• 50-Day Range: $14.00 to $14.00
• 52-Week Range: $9.90 to $14.81
• Volume: 4,200 shs
• Average Volume: 24,185 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VSPRU
• CIK: N/A
• Web: www.vesperhealth.com
• Phone: 786-216-7037
• Fax: N/A
• Employees: 1,030
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A